» Authors » Hiroyoshi Hattori

Hiroyoshi Hattori

Explore the profile of Hiroyoshi Hattori including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 567
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Iwakoshi A, Kikui H, Nakashima R, Goto Y, Ichikawa D, Sasaki E, et al.
Genes Chromosomes Cancer . 2024 Feb; 63(2):e23228. PMID: 38380728
An emerging group of spindle cell neoplasms harboring fusions involving NTRK or non-NTRK kinase genes often share characteristic S100 and/or CD34 expression; however, the diagnostic utility of immunohistochemical stains is...
2.
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, et al.
Int J Cancer . 2023 Feb; 152(12):2554-2566. PMID: 36727538
The efficacy of immune checkpoint inhibitors is limited in refractory solid tumors. T-cell receptor gene-modified T (TCR-T)-cell therapy has attracted attention as a new immunotherapy for refractory cold tumors. We...
3.
Ishihara M, Kitano S, Kageyama S, Miyahara Y, Yamamoto N, Kato H, et al.
J Immunother Cancer . 2022 Jun; 10(6). PMID: 35768164
Background: Because of the shortage of ideal cell surface antigens, the development of T-cell receptor (TCR)-engineered T cells (TCR-T) that target intracellular antigens such as NY-ESO-1 is a promising approach...
4.
Kawai M, Iijima-Yamashita Y, Taguchi I, Kataoka M, Sanada M, Murakami Y, et al.
Am J Case Rep . 2022 Jun; 23:e936455. PMID: 35700150
BACKGROUND Clonal hematopoiesis is the production of a specific single clonal type of cell in the blood and is often found in cancer genomic profiling tests. When the clone carries...
5.
Kumamoto T, Yamazaki F, Nakano Y, Tamura C, Tashiro S, Hattori H, et al.
Int J Clin Oncol . 2021 Dec; 27(1):262-263. PMID: 34859328
No abstract available.
6.
Kumamoto T, Yamazaki F, Nakano Y, Tamura C, Tashiro S, Hattori H, et al.
Int J Clin Oncol . 2021 Oct; 26(12):2161-2178. PMID: 34633580
Li-Fraumeni syndrome (LFS) is a hereditary tumor that exhibits autosomal dominant inheritance. LFS develops in individuals with a pathogenic germline variant of the cancer-suppressor gene, TP53 (individuals with TP53 pathogenic...
7.
Sugiyama K, Izumika A, Iwakoshi A, Nishibori R, Sato M, Shiraishi K, et al.
Curr Oncol . 2021 Jun; 28(3):1938-1945. PMID: 34064158
Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with alteration remains unclear. The patient...
8.
Kawada S, Futamura M, Hashimoto H, Ono M, Akita N, Sekimizu M, et al.
PLoS One . 2020 Oct; 15(10):e0240980. PMID: 33075082
Background: Cow's milk allergy (CMA) and egg allergy (EA) are common and can reduce quality of life in children. Infantile eczema is a well-established risk factor for the onset of...
9.
Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, et al.
Cancer Sci . 2020 Jul; 111(9):3367-3378. PMID: 32619037
Although next-generation sequencing-based panel testing is well practiced in the field of cancer medicine for the identification of target molecules in solid tumors, the clinical utility and clinical issues surrounding...
10.
Tsutsumi M, Hattori H, Akita N, Maeda N, Kubota T, Horibe K, et al.
BMC Med Genomics . 2019 Dec; 12(1):182. PMID: 31806026
Background: Female carriers of a balanced X; autosome translocation generally undergo selective inactivation of the normal X chromosome. This is because inactivation of critical genes within the autosomal region of...